Gene test aims to personalize sarcoma treatment

NCT ID NCT03784014

Completed Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether advanced genetic testing (called NGS) can be done quickly enough to help guide treatment choices for people with advanced soft-tissue sarcoma. About 600 adults with this rare cancer took part. The goal was to see if using genetic information to pick treatments could improve how long people live without their cancer getting worse.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neoplasm Metastasis sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOFT TISSUE SARCOMA

Contacts and locations

Locations

CHU Poitiers

Poitiers, 86000, France
Centre Antoine Lacassagne

Nice, France
Centre Eugène Marquis

Rennes, 35042, France
Centre Georges François Leclerc

Dijon, France
Centre Henri Becquerel

Rouen, France
Centre Léon Bérard

Lyon, France
Centre Oscar Lambret

Lille, France
Hôpital Cochin

Paris, France
Hôpital Pitié Salpétrière

Paris, France
ICANS - Institut de Cancérologie Strasbourg

Strasbourg, 67033, France
IUCT Oncopôle

Toulouse, France
Institut Bergonie

Bordeaux, France
Institut Curie

Paris, France
Institut Gustave Roussy

Villejuif, France
Institut Paoli Calmettes

Marseille, France
Institut de Cancérologie de Montpellier

Montpellier, France
Institut de Cancérologie de l'Ouest - Site René Gauducheau

Saint-Herblain, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.